Prospective selected biomarkers in COVID-19 diagnosis and treatment
| Autor: | Tahani Tabassum, Yusha Araf, Ahsan Ullah, Ahsab Rahman, Mohammad Jakir Hosen |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Coronavirus disease 2019 (COVID-19) Viral pathogenesis Clinical Biochemistry detection Review Severity of Illness Index pulmonary infections Risk groups stratification COVID-19 Testing Drug Discovery Severity of illness Pandemic medicine Global health Humans Lymphocyte Count Prospective Studies Intensive care medicine Prospective cohort study Serum Amyloid A Protein business.industry Platelet Count SARS-CoV-2 Biochemistry (medical) biomarkers COVID-19 Prognosis C-Reactive Protein Proper treatment business Procalcitonin |
| Zdroj: | Biomarkers in Medicine |
| ISSN: | 1752-0371 1752-0363 |
| Popis: | COVID-19 has become a global health concern, due to the high transmissible nature of its causal agent and lack of proper treatment. Early diagnosis and nonspecific medical supports of the patients appeared to be effective strategy so far to combat the pandemic caused by COVID-19 outbreak. Biomarkers can play pivotal roles in timely and proper diagnosis of COVID-19 patients, as well as for distinguishing them from other pulmonary infections. Besides, biomarkers can help in reducing the rate of mortality and evaluating viral pathogenesis with disease prognosis. This article intends to provide a broader overview of the roles and uses of different biomarkers in the early diagnosis of COVID-19, as well as in the classification of COVID-19 patients into multiple risk groups. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|